These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 9145784

  • 1. Tranilast inhibits the growth of rat mesangial cells.
    Ikeda M, Ikeda U, Shimada K, Fujita N, Okada K, Saito T, Minota S, Kano S.
    Eur J Pharmacol; 1997 Apr 18; 324(2-3):283-7. PubMed ID: 9145784
    [Abstract] [Full Text] [Related]

  • 2. Tranilast inhibits the effects of platelet-derived growth factor on cell proliferation and induction of nitric oxide.
    Hishikawa K, Nakaki T, Hirahashi J, Marumo T, Saruta T.
    Eur J Pharmacol; 1995 Nov 30; 291(3):435-8. PubMed ID: 8719431
    [Abstract] [Full Text] [Related]

  • 3. Altered nitric oxide production and exogenous nitric oxide do not affect the proliferation of rat mesangial cells.
    Mohaupt M, Schoecklmann HO, Schulze-Lohoff E, Sterzel RB.
    J Hypertens; 1994 Apr 30; 12(4):401-8. PubMed ID: 8064164
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tranilast restores cytokine-induced nitric oxide production against platelet-derived growth factor in vascular smooth muscle cells.
    Hishikawa K, Nakaki T, Hirahashi J, Marumo T, Saruta T.
    J Cardiovasc Pharmacol; 1996 Aug 30; 28(2):200-7. PubMed ID: 8856474
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries.
    Ward MR, Sasahara T, Agrotis A, Dilley RJ, Jennings GL, Bobik A.
    Atherosclerosis; 1998 Apr 30; 137(2):267-75. PubMed ID: 9622270
    [Abstract] [Full Text] [Related]

  • 8. Tranilast inhibits protein kinase C-dependent signalling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells.
    Koyama S, Takagi H, Otani A, Suzuma K, Nishimura K, Honda Y.
    Br J Pharmacol; 1999 May 30; 127(2):537-45. PubMed ID: 10385256
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lysophosphatidic acid and platelet-derived growth factor synergistically stimulate growth of cultured rat mesangial cells.
    Inoue CN, Ko YH, Guggino WB, Forster HG, Epstein M.
    Proc Soc Exp Biol Med; 1997 Dec 30; 216(3):370-9. PubMed ID: 9402141
    [Abstract] [Full Text] [Related]

  • 11. Eicosapentaenoic acid suppresses PDGF-induced DNA synthesis in rat mesangial cells: involvement of thromboxane A2.
    Schmitz PG, Zhang K, Dalal R.
    Kidney Int; 2000 Mar 30; 57(3):1041-51. PubMed ID: 10720956
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of the platelet-derived growth factor antagonist trapidil on mesangial cell proliferation in rats.
    Futamura A, Izumino K, Nakagawa Y, Takata M, Inoue H, Iida H.
    Nephron; 1999 Mar 30; 81(4):428-33. PubMed ID: 10095179
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Eicosapentaenoic acid inhibits mitogen-induced endothelin-1 production and DNA synthesis in cultured bovine mesangial cells.
    Nitta K, Uchida K, Tsutsui T, Honda K, Kawashima A, Yumura W, Nihei H.
    Am J Nephrol; 1998 Mar 30; 18(2):164-70. PubMed ID: 9569962
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.